Chemical peel clinics have a compliance problem that generic collaborating physician contracts don't solve: peel depth, not injectable volume, is what triggers physician-level oversight in most states. A medical director for chemical peel clinics needs to know the difference between a superficial glycolic peel and a 30% TCA peel, because state boards do too.
- A full-scope medical director program covering peel protocols and chart review is the Buy pick for clinics running TCA or Jessner peels above superficial depth in 2026.
- Good faith exam-only services work as a supplement for light peel add-ons but leave chart review gaps uncovered.
- Skip any collaborating physician who has never reviewed a burn escalation plan or signed off on a peel protocol.
- Medium and deep peels using 20%+ TCA trigger physician-level oversight requirements in most states as of 2026.
Why this matters
Most aesthetic clinics build their compliance stack around injectables first, then bolt on peels as a side service. That gets the oversight backwards. US Medical Directors works with estheticians and nurses who need coverage that actually accounts for peel depth, not just Botox units and filler syringes.
A medical director for chemical peel clinics who has never reviewed a peel protocol is signing paperwork, not providing oversight. That distinction matters in 2026 more than it did five years ago, as state boards have tightened language around delegated procedures that break the skin barrier — which is exactly what a medium-depth peel does.
Who this is for
This guide is for estheticians, RNs, and NPs running or expanding a chemical peel program at a medspa — especially anyone adding medium-depth (TCA 20-35%) or deep peels to a menu that used to be limited to superficial glycolic or salicylic treatments. If your clinic only offers light enzyme or lunchtime peels, your oversight needs are lighter. If you're moving into Jessner solution, higher-percentage TCA, or combination peels, the delegation rules change and so does what you need from a medical director.
What to look for in a medical director for chemical peel clinics
Peel-depth-specific delegation knowledge
A director who treats all peels the same is a red flag. Superficial peels are often within an esthetician's independent scope, while medium and deep peels typically require physician-level delegation and, in many states, an on-call or on-site physician. Ask directly which peel depths your state allows you to perform under supervision versus which ones need direct physician involvement.
Good faith exam turnaround before your first peel
Most states that require a good faith exam for injectables extend that requirement to medium and deep peels as well. A director who can't commit to a fast, predictable exam turnaround is going to slow down your onboarding of new peel clients, and clients don't wait around for paperwork.
Chart review cadence for adverse reactions
Chemical peels produce a different adverse-event profile than injectables — burns, unexpected hyperpigmentation, prolonged erythema. Your chart review process needs to specifically capture and document these events, not just track injection sites and lot numbers.
Scope match with your actual staff
A lot of collaborating physician agreements are written with Botox and filler injectors in mind and never mention exfoliating or chemical procedures at all. If your team is estheticians performing peels rather than nurses performing injections, confirm the agreement actually names peel procedures.
Complication escalation response time
A chemical burn from a mishandled peel needs a fast physician response, not a 48-hour callback window. Ask what the actual escalation SLA looks like in writing, and get a number, not a promise.
Multi-state and multi-location coverage
If you operate locations in more than one state, or you're a medspa network buying oversight in bulk, your medical director needs licensure and process consistency across every state you operate in — not a patchwork of separate contracts.
“If your collaborating physician has never signed off on a peel protocol, that’s not oversight — that’s a signature.”
Top picks for a medical director for chemical peel clinics
A full-scope medical director program — the standard setup. This model bundles physician oversight, chart review, and good faith exams under one agreement, and it's built to cover procedures beyond injectables, including peel protocols. Clinics running medium-depth peels alongside Botox and filler get one point of accountability instead of three separate vendors. Medical director services for medspas covers this setup in detail. Buy for any clinic adding TCA or Jessner peels above superficial depth in 2026.
A good faith exam-only service — the light-touch option. This covers the specific exam requirement many states attach to peels and injectables without bundling in ongoing chart review or protocol development. It's a reasonable fit for a clinic that already has a strong internal documentation process and just needs the exam itself handled correctly and on time. Good faith exams for medspas breaks down what states require. Consider it as a supplement, not a full compliance plan — it doesn't close the chart review gap.
A standalone chart review add-on — the compliance backstop. If you already have a medical director but your documentation for adverse peel reactions is thin, a dedicated chart review service catches gaps before a state board audit does. It's narrower in scope than a full program but fixes a specific, common weak point. Buy if your current director isn't reviewing peel-specific charts closely.
A generic injector-focused collaborating physician — the mismatch pick. Plenty of collaborating physician contracts were drafted for Botox and filler practices and simply never mention exfoliation, chemical exfoliants, or peel depth categories anywhere in the agreement. Signing one of these for a peel-heavy practice means you're paying for oversight that doesn't actually apply to half your service menu. Skip unless the agreement explicitly names peel procedures and depth thresholds.
Get oversight built for peel protocols
Coverage that accounts for peel depth, not just injectables.
What to avoid
- A director who never asks about peel percentage or depth. If the intake conversation never touches TCA concentration or peel category, they're not actually reviewing your procedures.
- Contracts with vague or slow response windows for adverse events. A 30-day check-in cycle is fine for routine chart review. It's not fine for a burn.
- Telehealth-only credentialing that isn't licensed in your specific state. Peel-related delegation rules are state-specific, and a director licensed two states over doesn't solve your compliance problem.
Verdict comparison
| Option | Best for | Covers peel protocols | Chart review included | Verdict |
|---|---|---|---|---|
| Full-scope medical director program | Clinics running medium/deep peels + injectables | Yes | Yes | Buy |
| Good faith exam-only service | Light peel add-ons with strong internal docs | Partial | No | Consider |
| Standalone chart review add-on | Clinics with weak documentation, existing director | Yes | Yes | Buy |
| Generic injector-focused agreement | Injectable-only practices | No | Rarely | Skip |
FAQ
Do chemical peel clinics need a medical director in 2026?
Most states require physician-level oversight once you move past superficial peels into medium-depth (TCA 20%+) or deep peels. A medical director for chemical peel clinics covers this delegation requirement along with good faith exams and chart review.
What peel depth triggers physician oversight requirements?
Medium-depth peels using roughly 20-35% TCA and deep peels typically require physician-level delegation in most states, while superficial glycolic or salicylic peels are often within an esthetician’s independent scope. Confirm your specific state’s threshold before adding stronger peels to your menu.
Is a good faith exam required before a chemical peel?
Many states that require a good faith exam for injectables extend the same requirement to medium and deep peels. Superficial peels are less consistently covered, so check your state’s rule directly rather than assuming.
How is a medical director for chemical peel clinics different from a general collaborating physician?
A general collaborating physician agreement is often written for injectable procedures and may never mention peel depth or exfoliation categories. A director focused on peel clinics reviews protocols specific to chemical exfoliants and burns, not just injection sites.
What should chart review cover for a peel-focused medspa?
Chart review for a peel clinic should document peel concentration, application time, adverse reactions like burns or prolonged erythema, and follow-up outcomes. This is different from injectable chart review, which tracks lot numbers and injection sites.
Can one medical director cover peel clinics in multiple states?
A director can cover multiple locations only if licensed and credentialed in each state where the clinic operates. Multi-location medspa networks should confirm state-by-state licensure before signing one agreement across all sites.
What happens if a peel causes a chemical burn without physician oversight?
Without documented physician-level oversight and a fast escalation path, a peel-related burn can expose the clinic to both a compliance violation and a liability gap. Escalation response time should be specified in writing, not left to an informal callback arrangement.
One last thing
Most clinics assume the state board scrutiny lands on injectables first. In practice, peel-related complaints often trace back to depth mismanagement — a technician running a 30% TCA peel under an agreement that only ever anticipated superficial glycolic work. The paperwork gap shows up exactly there, and it's the fastest thing a board finds in an audit.
Related guides
